238 related articles for article (PubMed ID: 19959801)
1. Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.
Gulley ML; Shea TC; Fedoriw Y
J Mol Diagn; 2010 Jan; 12(1):3-16. PubMed ID: 19959801
[TBL] [Abstract][Full Text] [Related]
2. A rational approach to genetic testing for sarcoma.
Gulley ML; Kaiser-Rogers KA
Diagn Mol Pathol; 2009 Mar; 18(1):1-10. PubMed ID: 19214114
[TBL] [Abstract][Full Text] [Related]
3. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract][Full Text] [Related]
4. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
[TBL] [Abstract][Full Text] [Related]
6. [Acute myeloid leukemia. Genetic diagnostics and molecular therapy].
Schlenk RF; Döhner K; Döhner H
Internist (Berl); 2013 Feb; 54(2):171-8. PubMed ID: 23358744
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype.
Haferlach C; Alpermann T; Schnittger S; Kern W; Chromik J; Schmid C; Pielken HJ; Kreuzer KA; Höffkes HG; Haferlach T
Blood; 2012 Mar; 119(9):2122-5. PubMed ID: 22207733
[TBL] [Abstract][Full Text] [Related]
9. Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.
Ommen HB; Schnittger S; Jovanovic JV; Ommen IB; Hasle H; Østergaard M; Grimwade D; Hokland P
Blood; 2010 Jan; 115(2):198-205. PubMed ID: 19901261
[TBL] [Abstract][Full Text] [Related]
10. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract][Full Text] [Related]
11. A novel hierarchical prognostic model of AML solely based on molecular mutations.
Grossmann V; Schnittger S; Kohlmann A; Eder C; Roller A; Dicker F; Schmid C; Wendtner CM; Staib P; Serve H; Kreuzer KA; Kern W; Haferlach T; Haferlach C
Blood; 2012 Oct; 120(15):2963-72. PubMed ID: 22915647
[TBL] [Abstract][Full Text] [Related]
12. Measurable residual disease testing for personalized treatment of acute myeloid leukemia.
Ehinger M; Pettersson L
APMIS; 2019 May; 127(5):337-351. PubMed ID: 30919505
[TBL] [Abstract][Full Text] [Related]
13. [Genetic abnormalities in AML].
Nakajima H
Rinsho Ketsueki; 2019; 60(6):584-593. PubMed ID: 31281149
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Molecular Markers in AML Patients: A Hospital-Based Study in Lebanon.
El Halabi L; Djaffar-Jureidini I; Hakime N; Saidy G; Chamseddine N
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S80-4. PubMed ID: 26297285
[TBL] [Abstract][Full Text] [Related]
15. Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis.
Giusiano S; Formisano-Tréziny C; Benziane A; Maroc N; Picard C; Hermitte F; Taranger-Charpin C; Gabert J
Int J Lab Hematol; 2010 Aug; 32(4):398-409. PubMed ID: 19930410
[TBL] [Abstract][Full Text] [Related]
16. Detection and Quantification of Acute Myeloid Leukemia-Associated Fusion Transcripts.
Schumacher J; Szankasi P; Kelley TW
Methods Mol Biol; 2017; 1633():151-161. PubMed ID: 28735486
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
18. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
19. Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia.
Cerveira N; Santos J; Bizarro S; Costa V; Ribeiro FR; Lisboa S; Correia C; Torres L; Vieira J; Snijder S; Mariz JM; Norton L; Mellink CH; Buijs A; Teixeira MR
BMC Cancer; 2009 May; 9():147. PubMed ID: 19445675
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
